Bowel Urgency in Crohn's Disease: Bridging the Gap Between Patients and Healthcare Providers

Bowel urgency (BU) is a prevalent and highly burdensome symptom among patients with inflammatory bowel disease. While BU is now recognized as a key symptom of ulcerative colitis, in the case of Crohn's disease (CD), it is often under-recognized by healthcare providers (HCPs) and inadequately captured in clinical assessments. Reported in up to 96% of patients with CD, BU can significantly impair quality of life, contributing to anxiety, social withdrawal, and reduced daily functioning. Despite its frequency and impact, BU is excluded from widely used CD activity indices and is infrequently included in clinical trial end points. An important challenge in the management of CD is the differing perceptions between patients and HCPs regarding the impact and importance of BU. This disconnect between patients and HCPs may lead to gaps in treatment and unmet patient needs. This narrative review synthesizes recent evidence on the prevalence, clinical significance, and underlying mechanisms of BU in CD. We also examine its impact on quality of life, evaluate current assessment tools, and highlight therapeutic approaches and gaps in HCP-patient communication. Greater awareness and systematic evaluation of BU as a multidimensional symptom of CD are critical for optimizing care and aligning clinical management with patient priorities.

Authors

Institutions

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-11-19
DOI
https://doi.org/10.14309/ajg.0000000000003858
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Bowel Urgency in Crohn's Disease: Bridging the Gap Between Patients and Healthcare Providers

Remo Panaccione, Richard Moses, Marla C. Dubinsky, Bénédicte Caron et al.
The American Journal of Gastroenterology
Inflammatory Bowel Disease
article

Bowel Urgency in Crohn's Disease: Bridging the Gap Between Patients and Healthcare Providers

Remo Panaccione, Richard Moses, Marla C. Dubinsky, Bénédicte Caron, Vipul Jairath, Aisha Vadhariya, Deborah A. Fisher, María Chaparro, Alison Potts Bleakman, Simon P.L. Travis, Alissa J. Walsh, Stephan R. Vavricka
article en

Abstract

Bowel urgency (BU) is a prevalent and highly burdensome symptom among patients with inflammatory bowel disease. While BU is now recognized as a key symptom of ulcerative colitis, in the case of Crohn's disease (CD), it is often under-recognized by healthcare providers (HCPs) and inadequately captured in clinical assessments. Reported in up to 96% of patients with CD, BU can significantly impair quality of life, contributing to anxiety, social withdrawal, and reduced daily functioning. Despite its frequency and impact, BU is excluded from widely used CD activity indices and is infrequently included in clinical trial end points. An important challenge in the management of CD is the differing perceptions between patients and HCPs regarding the impact and importance of BU. This disconnect between patients and HCPs may lead to gaps in treatment and unmet patient needs. This narrative review synthesizes recent evidence on the prevalence, clinical significance, and underlying mechanisms of BU in CD. We also examine its impact on quality of life, evaluate current assessment tools, and highlight therapeutic approaches and gaps in HCP-patient communication. Greater awareness and systematic evaluation of BU as a multidimensional symptom of CD are critical for optimizing care and aligning clinical management with patient priorities.

The American Journal of Gastroenterology
Western University (CA), Inserm (FR), Eli Lilly (United States) (US), University of Calgary (CA), John Radcliffe Hospital (GB), University Hospital of Zurich (CH), Hospital Universitario de La Princesa (ES), Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (ES), Oxford BioMedica (United Kingdom) (GB), Nutrition-Génétique et Exposition aux Risques Environnementaux (FR), Universidad Autónoma de Madrid (ES), Université de Lorraine (FR), Icahn School of Medicine at Mount Sinai (US)
Openalex Percentile: Top 61%
Inflammatory Bowel Disease
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.